NVNO:NASDAQenVVeno Medical Corporation Analysis
Data as of 2026-06-11 - not real-time
$10.27
Latest Price
8/10Risk
Risk Level: High
Executive Summary
NVNO is trading well below its short‑term and long‑term moving averages, with a bearish MACD crossover and an RSI hovering in the neutral zone. The price sits near a technical support area and faces resistance just above the current level, while volume has been on a downward trend and 30‑day volatility remains extremely high. Fundamentally, the company reports negative earnings, a negative forward P/E, and a very low price‑to‑book ratio, indicating a distressed valuation despite a modest cash position and limited debt.
The recent FDA IDE approval for a pivotal non‑surgical venous valve study provides a potential catalyst that could shift sentiment, but the lack of revenue and operating cash outflows keep the risk profile elevated.
The recent FDA IDE approval for a pivotal non‑surgical venous valve study provides a potential catalyst that could shift sentiment, but the lack of revenue and operating cash outflows keep the risk profile elevated.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD signal
- pending clinical data from FDA‑approved study
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- potential revenue lift if pivotal trial succeeds
- significant upside from low price‑to‑book valuation
- continued cash buffer despite operating losses
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- breakthrough medical‑device positioning in venous disease
- long‑term market opportunity if product gains regulatory clearance
- structural undervaluation relative to book value
Key Metrics & Analysis
Financial Health
P/E Ratio-8.6
ROE-60.65%
ROA-37.51%
Debt/Equity2.54
P/B Ratio0.3
Op. Cash Flow$-14788000
Free Cash Flow$-8367375
Industry P/E24.7
Technical Analysis
TrendBearish
RSI45.0
Support$9.04
Resistance$11.33
MA 20$10.54
MA 50$10.83
MA 200$16.16
MACDBearish
VolumeDecreasing
Fear & Greed Index84.2
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.04
Volatility62.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.